Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy.

Research into the disequilibrium of microglial phenotypes has become an area of intense focus in neurodegenerative disease as a potential mechanism that contributes to chronic neuroinflammation and neuronal loss in Parkinson's disease (PD). There is growing evidence that neuroinflammation accompanies and may promote progression of alpha-synuclein (Asyn)-induced nigral dopaminergic (DA) degeneration. From a therapeutic perspective, development of immunomodulatory strategies that dampen overproduction of pro-inflammatory cytokines from chronically activated immune cells and induce a pro-phagocytic phenotype is expected to promote Asyn removal and protect vulnerable neurons. Cannabinoid receptor-2 (CB2) is highly expressed on activated microglia and peripheral immune cells, is upregulated in the substantia nigra of individuals with PD and in mouse models of nigral degeneration. Furthermore, modulation of CB2 protects against rotenone-induced nigral degeneration; however, CB2 has not been pharmacologically and selectively targeted in an Asyn model of PD. Here, we report that 7 weeks of peripheral administration of CB2 inverse agonist SMM-189 reduced phosphorylated (pSer129) alpha-synuclein in the substantia nigra compared to vehicle treatment. Additionally, SMM-189 delayed Asyn-induced immune cell infiltration into the brain as determined by flow cytometry, increased CD68 protein expression, and elevated wound-healing-immune-mediator gene expression. Additionally, peripheral immune cells increased wound-healing non-classical monocytes and decreased pro-inflammatory classical monocytes. In vitro analysis of RAW264.7 macrophages treated with lipopolysaccharide (LPS) and SMM-189 revealed increased phagocytosis as measured by the uptake of fluorescence of pHrodo E. coli bioparticles. Together, results suggest that targeting CB2 with SMM-189 skews immune cell function toward a phagocytic phenotype and reduces toxic aggregated species of Asyn. Our novel findings demonstrate that CB2 may be a target to modulate inflammatory and immune responses in proteinopathies.

ASO-mediated knockdown or kinase inhibition of G2019S-Lrrk2 modulates lysosomal tubule-associated antigen presentation in macrophages.

Genetic variation around the LRRK2 gene affects risk for both familial and sporadic Parkinson's disease (PD). LRRK2 levels have become an appealing target for potential PD therapeutics with LRRK2 antisense oligonucleotides (ASOs) now moving toward clinical trials. However, LRRK2 has been suggested to play a fundamental role in peripheral immunity, and it is currently unknown if targeting increased LRRK2 levels in peripheral immune cells will be beneficial or deleterious. Here it was observed that G2019S macrophages exhibited increased stimulation-dependent lysosomal tubule formation (LTF) and MHC-II trafficking from the perinuclear lysosome to the plasma membrane in an mTOR-dependent manner with concomitant increases in pro-inflammatory cytokine release. Both ASO-mediated knockdown of mutant Lrrk2 and LRRK2 kinase inhibition ameliorated this phenotype and decreased these immune responses in control cells. Given the critical role of antigen presentation, lysosomal function, and cytokine release in macrophages, it is likely LRRK2-targeting therapies with systemic activity may have therapeutic value with regard to mutant LRRK2, but deleterious effects on the peripheral immune system, such as altered pathogen control in these cells, should be considered when reducing levels of non-mutant LRRK2.

The R1441C-LRRK2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner.

Considering age is the greatest risk factor for many neurodegenerative diseases, aging, in particular aging of the immune system, is the most underappreciated and understudied contributing factor in the neurodegeneration field. Genetic variation around the LRRK2 gene affects risk of both familial and sporadic Parkinson's disease (PD). The leucine-rich repeat kinase 2 (LRRK2) protein has been implicated in peripheral immune signaling, however, the effects of an aging immune system on LRRK2 function have been neglected to be considered. We demonstrate here that the R1441C mutation induces a hyper-responsive phenotype in macrophages from young female mice, characterized by increased effector functions, including stimulation-dependent antigen presentation, cytokine release, phagocytosis, and lysosomal function. This is followed by age-acquired immune cell exhaustion in a Lrrk2-kinase-dependent manner. Immune-exhausted macrophages exhibit suppressed antigen presentation and hypophagocytosis, which is also demonstrated in myeloid cells from R1441C and Y1699C-PD patients. Our novel findings that LRRK2 mutations confer immunological advantage at a young age but may predispose the carrier to age-acquired immune exhaustion have significant implications for LRRK2 biology and therapeutic development. Indeed, LRRK2 has become an appealing target in PD, but our findings suggest that more research is required to understand the cell-type specific consequences and optimal timing of LRRK2-targeting therapeutics.

Totally tubular: ASO-mediated knock-down of G2019S -Lrrk2 modulates lysosomal tubule-associated antigen presentation in macrophages.

Genetic variation around the LRRK2 gene affects risk of both familial and sporadic Parkinson's disease (PD). LRRK2 levels have become an appealing target for potential PD-therapeutics with LRRK2 antisense oligonucleotides (ASOs) now in clinical trials. However, LRRK2 has been suggested to play a fundamental role in peripheral immunity, and it is currently unknown if targeting increased LRRK2 levels in peripheral immune cells will be beneficial or deleterious. Furthermore, the precise role of LRRK2 in immune cells is currently unknown, although it has been suggested that LRRK2-mediated lysosomal function may be crucial to immune responses. Here, it was observed that G2019S macrophages exhibited increased stimulation-dependent lysosomal tubule formation (LTF) and MHC-II trafficking from the perinuclear lysosome to the plasma membrane in an mTOR dependent manner with concomitant increases in pro-inflammatory cytokine release. Both ASO-mediated knock down of mutant Lrrk 2 and LRRK2 kinase inhibition ameliorated this phenotype and decreased these immune responses in control cells. Given the critical role of antigen presentation, lysosomal function, and cytokine release in macrophages, it is likely LRRK2-targetting therapies may have therapeutic value with regards to mutant LRRK2 but deleterious effects on the peripheral immune system, such as altered pathogen control and infection resolution.

WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson's Disease Monocytes.

Both leucine-rich repeat kinase 2 (LRRK2) and glucocerebrosidase (GCase) are promising targets for the treatment of Parkinson's disease (PD). Evidence suggests that both proteins are involved in biological pathways involving the lysosome. However, studies to date have largely investigated the enzymes in isolation and any relationship between LRRK2 and GCase remains unclear. Both enzymes are highly expressed in peripheral blood monocytes and have been implicated in immune function and inflammation. To facilitate the standardized measurement of these readouts in large cohorts of samples collected from persons with PD across the globe, we developed and optimized a sample collection and processing protocol with parallel flow cytometry assays. Assay parameters were first optimized using healthy control peripheral blood mononuclear cells (PBMCs), and then LRRK2 and GCase activities were measured in immune cells from persons with idiopathic PD (iPD). We tested the ability of this protocol to deliver similar results across institutes across the globe, and named this protocol the Wallings-Hughes Optimized Protocol for PBMC Assessment (WHOPPA). In the application of this protocol, we found increased LRRK2 levels and stimulation-dependent enzymatic activity, and decreased GBA index in classical iPD monocytes, as well as increased cytokine release in PD PBMCs. WHOPPA also demonstrated a strong positive correlation between LRRK2 levels, pRab10 and HLA-DR in classical monocytes from subjects with iPD. These data support a role for the global use of WHOPPA and expression levels of these two PD-associated proteins in immune responses, and provide a robust assay to determine if LRRK2 and GCase activities in monocytes have potential utility as reliable and reproducible biomarkers of disease in larger cohorts of subjects with PD.

Kinetic stability and energetics of simulated glasses createdby constant pressure cooling.

We use computer simulations to study the cooling rate dependence of the stability and energetics of model glasses created at constant pressure conditions and compare the results with glasses formed at constant volume conditions. To examine the stability, we determine the time it takes for a glass cooled and reheated at constant pressure to transform back into a liquid, ttrans, and calculate the stability ratio S=ttrans/τα, where τα is the equilibrium relaxation time of the liquid. We find that, for slow enough cooling rates, cooling and reheating at constant pressure results in a larger stability ratio S than for cooling and reheating at constant volume. We also compare the energetics of glasses obtained by cooling while maintaining constant pressure with those of glasses created by cooling from the same state point while maintaining constant volume. We find that cooling at constant pressure results in glasses with lower average potential energy and average inherent structure energy. We note that in model simulations of the vapor deposition process, glasses are created under constant pressure conditions, and thus they should be compared to glasses obtained by constant pressure cooling.

Cooling-rate dependence of kinetic and mechanical stabilities of simulated glasses.

Glasses created through vapor deposition on a substrate maintained at a proper temperature possess higher kinetic and mechanical stabilities than glasses created by cooling at a constant rate. Molecular dynamics simulations are being increasingly used to understand why vapor deposition improves glasses' stability. There are, however, few detailed molecular dynamics studies of the dependence of the properties of glasses cooled at a constant rate on the rate of cooling. Thus, there is no clear benchmark for comparing ultrastable simulated glasses to simulated glasses prepared through cooling at a constant rate. Here, we examine the dependence of the properties of simulated glasses on the cooling rate used in their preparation. We examine the kinetic stability by measuring the time it takes for a glass to transform back to a liquid upon heating and heterogeneous dynamics during heating. We also examine properties of the energy landscape, and we evaluate mechanical stability by calculating the shear modulus of the glass. The methods outlined here can be used to assess kinetic and mechanical stabilities of simulated glasses generated using specialized algorithms and provide a benchmark for those algorithms.

Reduced strength and extent of dynamic heterogeneity in a strong glass former as compared to fragile glass formers.

We examined dynamic heterogeneity in a model tetrahedral network glass-forming liquid. We used four-point correlation functions to extract dynamic correlation lengths ξ4(a)(t) and susceptibilities χ4(a)(t) corresponding to structural relaxation on two length scales a. One length scale corresponds to structural relaxation at nearest neighbor distances and the other corresponds to relaxation of the tetrahedral structure. We find that the dynamic correlation length ξ4(a) grows much slower with increasing relaxation time than for model fragile glass formers. We also find that χ4(a)∼(ξ4(a))(z) for a range of temperatures, but z < 3 at the lowest temperatures examined in this study. However, we do find evidence that the temperature where Stokes-Einstein violation begins marks a temperature where there is a change in the character of dynamically heterogeneous regions. Throughout the paper, we contrast the structure and dynamics of a strong glass former with that of a representative fragile glass former.

Universal features of dynamic heterogeneity in supercooled liquids.

A few years ago it was shown that some systems that have very similar local structure, as quantified by the pair correlation function, exhibit vastly different slowing down upon supercooling. Recently, a more subtle structural quantity, the so-called "point-to-set" length, was found to reliably correlate with the average dynamics. Here we use computer simulations to examine the behavior of fluctuations around the average dynamics, i.e., dynamic heterogeneity. We study five model glass-forming liquids: three model liquids used in previous works and two additional model liquids with finite range interactions. Some of these systems have very similar local structure but vastly different dynamics. We show that for all these systems the spatial extent and the anisotropy of dynamic heterogeneity have the same correlation with the average dynamics. This result complements a recent experimental finding of a universal correlation between the number of correlated particles and the apparent activation enthalpy.